News Author: Jennifer Smith Publish date: February 12, 2021
A large study showed similar results with liquid and tissue biopsies while also revealing strengths and weaknesse...
News Author: Jennifer Smith Publish date: February 11, 2021
Adding saracatinib to docetaxel increased toxicity without improving efficacy.
News Author: Jennifer Smith Publish date: June 29, 2020
Prior treatment with steroids, anticoagulants, chemotherapy alone, or chemo plus immunotherapy were all associated with an increased risk of death....
News Author: Jennifer Smith Publish date: June 11, 2020
Nivolumab is approved for use in previously treated, unresectable, advanced, recurrent, or metastatic esophageal ...
News Author: Jennifer Smith Publish date: May 27, 2020
The combination of nivolumab, ipilimumab, and platinum-doublet chemotherapy is approved as frontline treatment fo...
News Author: Jennifer Smith Publish date: May 27, 2020
The FDA approved brigatinib to treat adults with ALK-positive metastatic non–small cell lung cancer and approved ...
News Author: Jennifer Smith Publish date: May 20, 2020
Atezolizumab is approved as first-line monotherapy for adults with metastatic non –sRead More
News Author: Jennifer Smith Publish date: May 11, 2020
The FDA has approved a new indication for olaparib and a companion diagnostic for adults with advanced epithelial...
News Author: Jennifer Smith Publish date: May 6, 2020
Capmatinib is the first FDA-approved treatment for NSCLC with MET exon 14 skipping mutations.
News Author: Jennifer Smith Publish date: May 1, 2020
Receiving antitumor treatment within 14 days of COVID-19 diagnosis was linked to a higher risk of ICU admission, ...
News Author: Jennifer Smith Publish date: April 29, 2020
Patients with hematologic malignancies or metastatic cancers had particularly high risks of developing severe or ...
News Author: Jennifer Smith Publish date: April 15, 2020
The FDA’s fast-track approval of mitomycin is based on results from the phase 3 OLYMPUS trial.
News Author: Jennifer Smith Publish date: March 31, 2020
A survey suggests a lack of discussion about clinical trials between doctors and patients with gynecologic cancers.
News Author: Jennifer Smith Publish date: March 19, 2020
About 77% of patients achieved a partial response or had stable disease on combination apatinib and vinorelbine.
News Author: Jennifer Smith Publish date: March 10, 2020
Locoregional control, distant metastasis, and survival rates were similar in patients who received the drug, GC4419, and those who did not.
